As of 2026-11-10, the EV/EBITDA ratio of Microbix Biosystems Inc (MBX.TO) is -15.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MBX.TO's latest enterprise value is 38.52 mil CAD. MBX.TO's TTM EBITDA according to its financial statements is -2.41 mil CAD. Dividing these 2 quantities gives us the above MBX.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-11-03 | -16.81 |
| 2026-11-02 | -16.24 |
| 2026-10-30 | -16.81 |
| 2026-10-29 | -16.24 |
| 2026-10-28 | -16.24 |
| 2026-10-27 | -17.09 |
| 2026-10-26 | -17.66 |
| 2026-10-23 | -17.94 |
| 2026-10-21 | -17.94 |
| 2026-10-20 | -17.94 |
| 2026-10-19 | -17.94 |
| 2026-10-16 | -16.81 |
| 2026-10-15 | -17.09 |
| 2026-10-14 | -17.09 |
| 2026-10-13 | -16.81 |
| 2026-10-09 | -17.37 |
| 2026-10-08 | -17.37 |
| 2026-10-07 | -17.66 |
| 2026-10-06 | -16.81 |
| 2026-10-05 | -16.81 |
| 2026-10-02 | -16.81 |
| 2026-09-30 | -17.37 |
| 2026-09-29 | -17.66 |
| 2026-09-28 | -16.81 |
| 2026-09-25 | -16.52 |
| 2026-09-24 | -16.52 |
| 2026-09-23 | -16.81 |
| 2026-09-22 | -17.09 |
| 2026-09-21 | -17.09 |
| 2026-09-18 | -16.81 |
| 2026-09-17 | -17.37 |
| 2026-09-16 | -17.37 |
| 2026-09-15 | -17.37 |
| 2026-09-14 | -17.37 |
| 2026-09-11 | -17.37 |
| 2026-09-10 | -16.24 |
| 2026-09-09 | -16.52 |
| 2026-09-08 | -15.67 |
| 2026-09-04 | -16.52 |
| 2026-09-03 | -16.24 |
| 2026-09-02 | -16.24 |
| 2026-09-01 | -16.81 |
| 2026-08-31 | -16.81 |
| 2026-08-28 | -17.94 |
| 2026-08-27 | -17.94 |
| 2026-08-26 | -17.37 |
| 2026-08-25 | -16.81 |
| 2026-08-24 | -17.37 |
| 2026-08-21 | -16.81 |
| 2026-08-20 | -16.24 |